ArticlebioRxiv : the preprint server for biology2025
LAG3+ CD8+ T cell Subset Drives HR+/HER2- Breast Cancer Reduction in Bispecific Antibody Armed Activated T Cell Therapy.
Robert Weldon Barnes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.